Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Tilray

What 4 Analyst Ratings Have To Say About Tilray

Tilray (NASDAQ:TLRY) has observed the following analyst ratings within the last quarter:

Benzinga

Tilray Poised To Conquer Malta's Medical Marijuana Market - Launches First Medical Cannabis Oil

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) confrimed Thursday that its medical cannabis division, Tilray Medical, has expanded its medical cannabis offering and launched the first EU GMP medical cannabis oil products in Malta.

Benzinga

Irwin Simon, At The Helm Of One Of The Biggest Cannabis Operators, Tilray: Meet Our Keynote Speakers

Who is the person behind the largest Canadian cannabis company in the world? That would be Irwin D. Simon, chairman and CEO of Tilray Brands Inc. (NASDAQ: TLRY).

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

HEXO Elects Seven Directors At Its Shareholders Meeting On The Heels Of Tilray Deal

HEXO Corp. (NASDAQ: HEXO) (TSX:HEXO) elected seven directors at the annual general and special meeting of shareholders held on March 8, 2022.

Benzinga

What Does Tilray Get From HEXO Debt Deal? Analyst Says 'Chapeau!' To CEO Irwin Simon

On Thursday, HEXO Corp. (NASDAQ: HEXO) finalized a strategic partnership with Tilray Brands, Inc.

Benzinga

Tilray Continues To Crash After Partnership Announcement: What's Next?

Tilray Inc. (NASDAQ: TLRY) shares are trading lower Thursday and are continuing the downward trend the stock has been on.

Benzinga

Why HEXO Shares Are Trading Higher Today

HEXO Corp (NASDAQ: HEXO) is trading higher Thursday after the company announced a strategic partnership with Tilray Brands Inc (NASDAQ: TLRY) which includes a new debt financing agreement.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Chart Wars: Between Sundial And Tilray, Which Marijuana Stock Could Smoke Shorts First?

Sundial Growers Inc (NASDAQ: SNDL) was trading slightly higher on Wednesday, while Tilray, Inc (NASDAQ: TLRY) was trading down about 2%.

Benzinga

Tilray's Subsidiary Manitoba Harvest To Present Its New Product Line 'Power Of Hemp'

Tilray's (NASDAQ: TLRY) subsidiary Manitoba Harvest, a hemp foods brand will unveil its new product lineup at the upcoming Natural Products Expo West, to be held March 10-12 in Anaheim, CA.

Benzinga

Aurora Cannabis Is Selling Stock To Pay Off Debt: Why Tilray And Canopy Could Be Next In Line

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slig

Benzinga

Where Will Tilray's Stock Be In 2025? Survey Says...

Tilray Inc (NASDAQ: TLRY), a Canadian pharmaceutical and cannabis company, is one of the most popular cannabis stocks out there. Back in 2018, the stock ran all the way to $148 before coming back down to the single digits.

Benzinga

Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified

Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) has appointed Ana Bowman as a chief financial officer, effective February 22.

Benzinga

Tilray Launches Medical Cannabis Products In Malta

Tilray Brands, Inc.

Benzinga

Weed'n Whiskey: Why Tilray Thinks There Is Gold In Cannabis-Infused Whiskey

This article was originally published on Cannabis.net and appears here with permission.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Benzinga

Tilray Stock Is Having A Green Day: What's Going On?

Tilray Inc.

Benzinga

Tilray Consolidates Its Portfolio Of Brands & Products Into Tilray Medical

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform

Benzinga

Chart Wars: Between Tilray And Canopy Growth, Which Cannabis Stock Could Slam Shorts Harder?

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) soared 10.59% and 8.76%, respectively, on Monday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Tilray Expands Medical Marijuana Product Offering In Australia, Launches Cannabis E-Learning Platform

Marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced on Tuesday the expansion of its medical cannabis product offering in Australia and the launch of a new medical cannabis e-learning platform for healthcare providers.

Benzinga

EXCLUSIVE: Why One Top Hedge Fund Manager Is Bullish On US Cannabis Stocks

Investment expert and former hedge fund manager Whitney Tilson, current president and CEO of Empire Financial Research, recently stopped by Benzinga Cannabis Hour to discuss his investment thesis including his 2022 outlook as it pertains to the

Kiplinger

Best Marijuana Stocks to Buy: Cannabis Stocks for Investing

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Canopy Growth Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.